(Press-News.org) Neena Singh, MD, PhD and colleagues at Case Western Reserve University School of Medicine have identified the first disease-specific biomarker for sporadic Creutzfeldt-Jakob disease (sCJD), a universally fatal, degenerative brain disease for which there is no cure. sCJD is one of the causes of dementia and typically leads to death within a year of disease onset.
The finding, published in the March 9th issue of PLoS ONE, a scientific journal produced by the Public Library of Science, provides a basis for developing a test to diagnosis sCJD while patients are still alive. Presently, the only definitive diagnostic test for the disease requires brain tissue be obtained by biopsy or after death.
In their study, Dr. Singh, associate professor of pathology at the School of Medicine, and her team found that levels of the iron-transport protein transferrin (Tf) are significantly decreased in the cerebrospinal fluid (CSF) of patients with sCJD well before the end stage of the disease, potentially allowing for earlier diagnosis.
"The decrease in Tf is significant enough to distinguish sCJD from dementia of non-CJD origin with an accuracy of 80 percent," Dr. Singh says. "When combined with the currently used non-disease-specific biomarker T-tau, the diagnostic accuracy increases to 86 percent. This suggests that the two biomarkers represent separate disease processes, and complement each other as diagnostic biomarkers."
A decrease in the levels of CSF Tf reflects the imbalance of brain's iron metabolism that is associated with sCJD. Being a part of the sCJD disease process, CSF Tf is likely to be a more precise indicator of sCJD than the current tests, Dr. Singh explains.
"CSF Tf is the first biomarker that is related to the underlying pathology in sCJD brains," Dr. Singh explains.
Presently, sCJD is diagnosed by testing for elevated levels of the proteins 14-3-3 and T-tau in the CSF of cases suspected of the disease. Since these biomarkers are elevated in several other diseases besides sCJD, the incidence of false positive results is high. Replacement of 14-3-3 with Tf increases the specificity of the test significantly, providing a superior biomarker combination for the diagnosis of sCJD.
The ability to accurately diagnose patients while they are still living is critical to prevent inadvertent spread of sCJD to healthy individuals, to reduce the misdiagnosis of potentially treatable causes of dementia, and to eventually develop potential therapies for sCJD, according to Dr. Singh.
As a part of their study, Dr. Singh and her team estimated levels of Tf in the CSF collected up to 24 months before death from confirmed cases of sCJD (n=99) and dementia of non-CJD origin (n=74). They found that levels of Tf were decreased significantly in sCJD cases compared to dementia of non-CJD origin. Further testing revealed that measurement of CSF Tf alone identified sCJD with a sensitivity of 85 percent, specificity of 72 percent, and accuracy of 80 percent. When combined with the surrogate biomarker T-tau, the CSF Tf and T-tau combination identified sCJD with an improved specificity of 87 percent and accuracy of 86 percent according to the research.
In addition to providing improved diagnostic accuracy, Dr. Singh notes that CSF Tf has several other advantages. It is resistant to degradation by enzymes, ensuring consistent results even in poorly preserved CSF samples; Tf-β2, the brain specific isoform of Tf is equally efficient in identifying sCJD and is likely to provide accurate results even from samples that are accidentally contaminated with blood during the collection process; and, Tf is abundant in the CSF relative to the currently used biomarkers 14-3-3 and T-tau, allowing accurate diagnosis from a small sample volume.
Moving forward, researchers will work to establish a user-friendly, quantitative test for CSF Tf to provide a quick and uniform method of diagnosis for sCJD. They will also continue testing CSF samples from sCJD and other forms of human and animal prion disorders to establish the earliest time point in the disease course when this test becomes positive.
###
Citation: Singh A, Beveridge AJ, Singh N (2011) Decreased CSF Transferrin in sCJD: A Potential Pre-Mortem Diagnostic Test for Prion Disorders. PLoS ONE 6(3):
e16804. doi:10.1371/journal.pone.0016804
Funding: This study was supported by funds from National Institutes of Health grant R21AG109106 to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
New biomarker for Creutzfeldt-Jakob disease found, the human form of mad cow disease
2011-03-10
ELSE PRESS RELEASES FROM THIS DATE:
Missing DNA helps make us human
2011-03-10
A new study demonstrates that specific traits that distinguish humans from their closest living relatives – chimpanzees, with whom we share 96 percent of our DNA – can be attributed to the loss of chunks of DNA that control when and where certain genes are turned on. The finding mirrors accumulating evidence from other species that changes to regulatory regions of DNA – rather than to the genes themselves – underlie many of the new features that organisms acquire through evolution.
Seeking specific genetic changes that might be responsible for the evolution of uniquely ...
Cerebral spinal fluid guides stem cell development in the brain
2011-03-10
Cerebrospinal fluid—the clear and watery substance that bathes the brain and spinal cord—is much more important to brain development than previously realized.
Howard Hughes Medical Institute investigator Christopher Walsh, his postdoctoral fellow Maria Lehtinen, former student Mauro Zappaterra, and their colleagues have discovered that cerebrospinal fluid (CSF) contains a complex mix of proteins that changes dramatically with age. In the lab, CSF by itself is enough to support the growth of neural stem cells, and this effect is particularly robust in young brains.
What's ...
Protein study helps shape understanding of body forms
2011-03-10
Scientists have shed light on why some people are apple-shaped and others are pear-shaped.
Researchers at the University of Edinburgh have pinpointed a protein that plays a part in how fat is stored in the body.
The latest findings give greater understanding of how the protein works, which could help development of medicines to treat obesity.
Levels of the protein – known as 11BetaHSD1 – tend to be higher in the presence of an unhealthy type of body fat which tends to be stored around the torso – typical of "apple-shapes".
Healthier fat, linked to lower levels ...
Abnormal neural activity recorded from the deep brain of Parkinson's disease and dystonia patients
2011-03-10
Movement disorders such as Parkinson's diseases and dystonia are caused by abnormal neural activity of the basal ganglia located deep in the brain. The basal ganglia are connected to the cerebral cortex in the brain surface through complex neural circuits. Their basic structure and connections, as well as the dysfunctions in movement disorders, have been examined extensively by using experimental animals. On the other hand, little is known about the human brain that is much more complex in either normal or diseased states.
An international joint research team led by ...
High-volume portable music players may impair ability to clearly discriminate sounds
2011-03-10
Growing numbers of people enjoy listening to music on portable music players or cell phones, and many tend to turn up the volume, especially in noisy surroundings. In a study published March 2, 2011 in the open-access journal PLoS ONE, researchers explore the potential effects of this behavior on hearing.
The study was a collaboration between Drs. Hidehiko Okamoto and Ryusuke Kakigi from the National Institute for Physiological Sciences, Japan, and Drs. Christo Pantev and Henning Teismann from the University of Muenster. The researchers demonstrated that listening to ...
Sunlight can influence the breakdown of medicines in the body
2011-03-10
A study from the Swedish medical university Karolinska Institutet has shown that the body's ability to break down medicines may be closely related to exposure to sunlight, and thus may vary with the seasons. The findings offer a completely new model to explain individual differences in the effects of drugs, and how the surroundings can influence the body's ability to deal with toxins.
The study will be published in the scientific journal Drug Metabolism & Disposition and is based on nearly 70,000 analyses from patients who have undergone regular monitoring of the levels ...
Reading in 2 colours at the same time
2011-03-10
Milan, Italy, 9 March 2011 – The Nobel prize-winning physicist Richard Feynman once wrote in his autobiographical book (What do you care what other people think?): "When I see equations, I see letters in colors - I don't know why […] And I wonder what the hell it must look like to the students." This neurological phenomenon is known to psychologists as synaesthesia and Feynman's experience of "seeing" the letters in colour was a specific form known today as "grapheme-colour" synaesthesia. What is perhaps most puzzling about this condition is that people actually claim to ...
U of M researchers using salmonella to fight cancer
2011-03-10
MINNEAPOLS / ST. PAUL (March 9, 2011) – University of Minnesota researchers are using salmonella – the bacteria commonly transmitted through food that sickens thousands of U.S. residents each year – to do what was once unthinkable: help people.
U of M Masonic Cancer Center researchers believe salmonella may be a valuable tool in the fight against cancer in organs surrounding the gut – such as the liver, spleen, and colon – since that's where salmonella naturally infects the body.
Researchers want to "weaponize" salmonella, allowing the bacteria to then attack cancer ...
Baby stars born to 'napping' parents
2011-03-10
Cardiff University astronomers believe that a young star's long "napping" could trigger the formation of a second generation of smaller stars and planets orbiting around it.
It has long been suspected that the build up of material onto young stars is not continuous but happens in episodic events, resulting in short outbursts of energy from these stars.
However, this has been largely ignored in models of star formation.
Now, by developing advanced computer models to simulate the behaviour of young stars, Cardiff University Astrophysicists Dr Dimitris Stamatellos and ...
Aspirin's ability to protect against colorectal cancer may depend on inflammatory pathways
2011-03-10
The reduced risk of colorectal cancer associated with taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood. In a paper in the March issue of Gastroenterology, investigators from Massachusetts General Hospital (MGH) and Dana-Farber Cancer Institute report finding that higher baseline levels of a novel inflammatory marker indicated increased risk of developing colorectal tumors and also predicted who might benefit from taking aspirin or NSAIDs. ...